Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

L Tonneijck, MM Smits, MHA Muskiet, T Hoekstra, MHH Kramer, Jan Danser, PM ter Wee, M Diamant, JA Joles, DH van Raalte

Research output: Contribution to journalArticleAcademicpeer-review

73 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2042-2050
Number of pages9
JournalDiabetes Care
Issue number11
Publication statusPublished - 2016

Cite this